Sage Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Sage Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Sage Capital Management from 13F filings

Historical chart of Sage Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Sage Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Sage Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $220k 472 465.08
2024-06-30 $221k 472 468.72

More positions owned by Sage Capital Management

NVIDIA Corporation (NVDA)
Global X Fds Us Infr Dev Etf (PAVE)
Select Sector Spdr Tr Technology (XLK)
Invesco Exchange Traded Fd T Water Res Etf (PHO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amplify Etf Tr Amplify Cybersec (HACK)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Ser Tr Factst Inv Etf (XITK)
Wisdomtree Tr Us Midcap Divid (DON)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Ea Series Trust Strive 500 Etf (STRV)
International Business Machines (IBM)

View all positions for Sage Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated